PMID: 9549635Apr 29, 1998Paper

Renal dysfunction does not alter the pharmacokinetics or LDL-cholesterol reduction of atorvastatin

Journal of Clinical Pharmacology
R H SternS C Olson

Abstract

The objective of this study was to determine the effects of renal dysfunction on the steady-state pharmacokinetics and pharmacodynamics of atorvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. Nineteen subjects with calculated creatinine clearances ranging from 13 mL/min to 143 mL/min were administered 10 mg atorvastatin daily for 2 weeks. Pharmacokinetic parameters and lipid responses were analyzed by regression on calculated creatinine clearance. Correlations between steady-state atorvastatin pharmacokinetic or pharmacodynamic parameters and creatinine clearance were weak and, in general, did not achieve statistical significance. Although the elimination rate constant, lambda z (0.579), was significantly correlated with creatinine clearance, neither maximum plasma concentration (Cmax, -0.361) nor oral clearance (Cl/F, 0.306) were; thus, steady-state exposure is not altered. Renal impairment has no significant effect on pharmacodynamics and pharmacokinetics of atorvastatin.

References

Feb 1, 1992·Journal of Clinical Pharmacology·C E HalstensonH Pan
Oct 1, 1991·Clinical Pharmacology and Therapeutics·S QuérinP Larochelle
Feb 1, 1994·Journal of Clinical Pharmacology·R L Talbert
Mar 1, 1996·Journal of Clinical Pharmacology·D M GibsonL R Whitfield

❮ Previous
Next ❯

Citations

Dec 16, 2006·Current Atherosclerosis Reports·Peter A McCullough, Leslie R Rocher
Dec 11, 2007·International Urology and Nephrology·Kosmas I Paraskevas
Feb 8, 2008·Current Diabetes Reports·Peter A McCullough, Leslie R Rocher
Oct 5, 2001·The American Journal of Medicine·P H ChongC Franklin
Mar 29, 2002·Kidney International·Kevin P G HarrisUNKNOWN Atorvastatin in CAPD Study Investigators. Continuous ambulatory peritoneal dialysis
May 20, 2003·Seminars in Dialysis·Stephen L Seliger, Catherine O Stehman-Breen
Apr 11, 2003·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Robert L LinsNorbert H Lameire
Feb 22, 2002·Current Opinion in Nephrology and Hypertension·Domenic A Sica, Todd W B Gehr
Sep 15, 2006·Seminars in Dialysis·Jia LiuMitchell H Rosner
Sep 8, 2000·Clinical Pharmacokinetics·W Mück
May 31, 2002·Clinical Pharmacokinetics·David Williams, John Feely
Jun 30, 2005·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Hallvard Holdaas
Sep 8, 2010·Clinical Pharmacokinetics·Rajesh NarwalSara E Rosenbaum
Apr 20, 2010·Enfermedades infecciosas y microbiología clínica·UNKNOWN Panel de expertos del Grupo de Estudio de Sida (GESIDA) y del Plan Nacional sobre el Sida (PNS)
Feb 17, 2009·Endocrinology and Metabolism Clinics of North America·Terri Montague, Barbara Murphy
Feb 14, 2009·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Michael J KorenUNKNOWN ALLIANCE Investigators
Oct 29, 2015·Forensic Science International : Synergy·Lubica CibickovaNorbert Cibicek
Oct 1, 2008·Journal of Clinical Lipidology·Peter A McCulloughAdam Whaley-Connell
Apr 30, 2005·International Journal of Cardiology·Vincent Launay-VacherGilbert Deray
Apr 12, 2005·Advances in Chronic Kidney Disease·Samir ShahFarhad R Danesh
Oct 9, 2002·Angiology·Moses Elisaf, Dimitri P Mikhailidis
Mar 19, 2004·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·B KasiskeUNKNOWN National Kidney Foundation
Oct 19, 2007·Clinical Journal of the American Society of Nephrology : CJASN·James ShepherdUNKNOWN Treating to New Targets Investigators
Aug 21, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Joseph Nogueira, Matthew Weir
May 16, 2000·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·G HufnagelF Mignon
Jul 9, 2002·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·A AsbergH Holdaas
Nov 24, 2016·The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG·Jonathan Wagner, Susan M Abdel-Rahman
Oct 30, 1998·The Annals of Pharmacotherapy·H S Yee, N T Fong
Jul 25, 2020·Clinical Pharmacology and Therapeutics·Daniel A TatosianS Aubrey Stoch

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Robert L LinsNorbert H Lameire
© 2022 Meta ULC. All rights reserved